INSIDER
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources
SEC FORM 44h ago
HOUSE PTR4h ago
SEC 13F4h ago
ROBINHOOD CHAIN4h ago
SEC FORM 4/Grant or awardVerified data

Fargis Edward C reported PRVA

EVP & General Counsel · Privia Health Group, Inc. · Common Stock, $0.01 par value per share

Side
A
Value
—
Shares
28.3K
Price
—
Executed
Mar 10, 2026
Disclosed
Mar 12, 2026
Disclosure timeline2 days from execution to publication · legal deadline 2 business days
Mar 10 executedMar 12, 2026 disclosed

PRVA · daily

Yahoo Finance chart API
▲Execution▼Disclosure●Material company filing●Other disclosed buy●Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.

Insider Score

Experimental signal
17/ 100 · ROUTINE
Methodology →
  • Transaction type0 / 20

    Grant or award — administrative, little informational value

  • Relative size+9 / 25

No reported dollar value · 33.8% of prior position

  • Filing timing0 / 15

    Disclosed 2 business days after execution (deadline: 2)

  • Historical behavior+8 / 15

    First recorded trade by this actor in this security

  • Frequency & clustering0 / 15

    No clustered activity in the dataset

  • Market events0 / 10

    No material company filing within 60 days after the trade

    • The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.

    Other disclosed activity · PRVA

    ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
    22
    MD
    Mountcastle DavidEVP & Chief Financial Officer
    PRVAPrivia Health Group, Inc.
    Open-market sale · 10b5-1 plan
    		SELL$680K
    24.7K sh
    		Jul 2, 2026Jul 7, 2026
    traded Jul 2, 2026
    		+5dSEC FORM 4

    Evidence

    0
    MD
    Mountcastle DavidEVP & Chief Financial Officer
    PRVAPrivia Health Group, Inc.
    Option exercise · 10b5-1 plan
    		M—
    8,897 sh
    		Jun 26, 2026Jun 30, 2026
    traded Jun 26, 2026
    		+4dSEC FORM 4

    Evidence

    0
    MD
    Mountcastle DavidEVP & Chief Financial Officer
    PRVAPrivia Health Group, Inc.
    Option exercise · 10b5-1 plan
    		M—
    1,001 sh
    		Jun 26, 2026Jun 30, 2026
    traded Jun 26, 2026
    		+4dSEC FORM 4

    Evidence

    0
    MD
    Mountcastle DavidEVP & Chief Financial Officer
    PRVAPrivia Health Group, Inc.
    Option exercise · 10b5-1 plan
    		M—
    1,336 sh
    		Jun 26, 2026Jun 30, 2026
    traded Jun 26, 2026
    		+4dSEC FORM 4

    Evidence

    14
    MS
    Morris Matthew ShawnDirector
    PRVAPrivia Health Group, Inc.
    Option exercise · 10b5-1 plan
    		M$176K
    88.1K sh
    		Jun 26, 2026Jun 30, 2026
    traded Jun 26, 2026
    		+4dSEC FORM 4

    Evidence

    31
    MS
    Morris Matthew ShawnDirector
    PRVAPrivia Health Group, Inc.
    Open-market sale · 10b5-1 plan
    		SELL$2.23M
    88.1K sh
    		Jun 26, 2026Jun 30, 2026
    traded Jun 26, 2026
    		+4dSEC FORM 4

    Evidence

    10
    MS
    Morris Matthew ShawnDirector
    PRVAPrivia Health Group, Inc.
    Option exercise · 10b5-1 plan
    		M$126K
    63.2K sh
    		Jun 29, 2026Jun 30, 2026
    traded Jun 29, 2026
    		+1dSEC FORM 4

    Evidence

    23
    MS
    Morris Matthew ShawnDirector
    PRVAPrivia Health Group, Inc.
    Open-market sale · 10b5-1 plan
    		SELL$1.60M
    63.2K sh
    		Jun 29, 2026Jun 30, 2026
    traded Jun 29, 2026
    		+1dSEC FORM 4

    Evidence

    0
    MS
    Morris Matthew ShawnDirector
    PRVAPrivia Health Group, Inc.
    Option exercise · 10b5-1 plan
    		M—
    88.1K sh
    		Jun 26, 2026Jun 30, 2026
    traded Jun 26, 2026
    		+4dSEC FORM 4

    Evidence

    0
    MS
    Morris Matthew ShawnDirector
    PRVAPrivia Health Group, Inc.
    Option exercise · 10b5-1 plan
    		M—
    63.2K sh
    		Jun 29, 2026Jun 30, 2026
    traded Jun 29, 2026
    		+1dSEC FORM 4

    Evidence

    0
    MD
    Mountcastle DavidEVP & Chief Financial Officer
    PRVAPrivia Health Group, Inc.
    Option exercise · 10b5-1 plan
    		M$34K
    17.2K sh
    		Jun 26, 2026Jun 30, 2026
    traded Jun 26, 2026
    		+4dSEC FORM 4

    Evidence

    16
    MD
    Mountcastle DavidEVP & Chief Financial Officer
    PRVAPrivia Health Group, Inc.
    Open-market sale · 10b5-1 plan
    		SELL$433K
    17.2K sh
    		Jun 26, 2026Jun 30, 2026
    traded Jun 26, 2026
    		+4dSEC FORM 4

    Evidence

    0
    MD
    Mountcastle DavidEVP & Chief Financial Officer
    PRVAPrivia Health Group, Inc.
    Option exercise · 10b5-1 plan
    		M—
    5,962 sh
    		Jun 26, 2026Jun 30, 2026
    traded Jun 26, 2026
    		+4dSEC FORM 4

    Evidence

    20
    MD
    Mountcastle DavidEVP & Chief Financial Officer
    PRVAPrivia Health Group, Inc.
    Open-market sale
    		SELL$77K
    3,385 sh
    		May 11, 2026May 13, 2026
    traded May 11, 2026
    		+2dSEC FORM 4

    Evidence

    24
    MD
    Mountcastle DavidEVP & Chief Financial Officer
    PRVAPrivia Health Group, Inc.
    Open-market sale
    		SELL$116K
    5,566 sh
    		Apr 2, 2026Apr 6, 2026
    traded Apr 2, 2026
    		+4dSEC FORM 4

    Evidence

    Evidence

    Verified data

    Read directly from the primary public document; every field below is as reported by the filer.

    Source

    Document
    SEC Form 4
    Publisher
    U.S. Securities and Exchange Commission (EDGAR)
    Document ID
    0002009323-26-000002
    Machine-readable
    Structured copy

    Timestamps

    Event (reported)
    Mar 10, 2026
    Published
    Mar 12, 2026
    Ingested by INSIDER
    Nov 5, 04:12 UTC
    Last re-read
    Nov 5, 04:12 UTC

    Extracted facts

    Filer
    Fargis Edward C
    Role
    EVP & General Counsel
    Transaction
    Grant or awardAs filed: “A”
    Asset
    Privia Health Group, Inc.
    Ticker
    PRVA
    Shares
    28.3K
    Price per share
    $0
    Execution date (reported)
    Mar 10, 2026
    Owned after transaction
    112.0K shares
    Days from execution to publication
    2

    What this establishes

    Fargis Edward C filed this Form 4 reporting a grant or award of PRVA on Mar 10, 2026. It became public on Mar 12, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.

    Extraction

    Method
    Form 4 XML
    Confidence
    1.00
    EVP & General Counsel
    Fargis Edward Ccik:0002009323
    Issuer
    Privia Health Group, Inc.cik:0001759655

    Revision history · 0

    No field has changed since this record was first ingested.

    Company events

    No records

    No material filings recorded for this issuer.